Dow Up 1.63% Nasdaq Up 0.97%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.01 0.03(0.74%) Oct 17, 4:00PM EDT
Prev Close:4.04
Open:4.12
Bid:3.99 x 400
Ask:4.23 x 1400
1y Target Est:6.57
Beta:-3.58
Earnings Date:Oct 27 - Nov 6 (Est.)
Day's Range:3.97 - 4.20
52wk Range:3.26 - 7.97
Volume:3,825,287
Avg Vol (3m):4,490,250
Market Cap:881.54M
P/E (ttm):N/A
EPS (ttm):-0.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARNA

Comparison

Symbol% ChgMkt Cap
ARNADown 0.74%881.54M
GSK104.90B
OREX499.94M
RHHBY240.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):29.89
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.32
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback